In a patient with community-acquired pneumonia admitted to the general medical floor, which antibiotic would be most appropriate to add to empiric ceftriaxone?

• A. Piperacillin
• B. Vancomycin
• C. Clindamycin
• D. Azithromycin

Answer: (D)

Community-acquired pneumonia on the general medical floor is typically treated with a regimen that covers both typical bacteria (like Streptococcus pneumoniae and Haemophilus influenzae) and atypical pathogens (such as Mycoplasma, Chlamydophila, and Legionella). Ceftriaxone effectively targets many typical respiratory pathogens but does not reliably cover atypicals. Adding a macrolide like azithromycin fills this gap by providing robust coverage against the atypical organisms, which is why it’s the best addition to empiric therapy in this setting.

The other options aren’t as appropriate here: piperacillin is a broad-spectrum agent more often reserved for suspected Pseudomonas or more severe hospital-acquired infections; vancomycin targets MRSA and is not routinely added for uncomplicated CAP on a general ward; clindamycin covers some typical pathogens but has poor and unreliable atypical coverage. Azithromycin’s ability to cover both typical and atypical pathogens makes it the most suitable choice in this scenario.